HOME >> BIOLOGY >> NEWS
Stanford launches public lecture series on genomic medicine

Stanford University is offering a series of free monthly lectures designed to enhance public understanding of the Human Genome Project and the revolution in genomic medicine. The lecture series, titled ''Sequencing the Human Genome: What Does It Tell Us About Ourselves,'' will be held in Fairchild Auditorium on the Stanford campus.

The first lecture, "Biomedical Innovations: Confronting the Polity," will be presented by Nobel laureate Paul Berg on Monday, Jan. 26, at 6 p.m. PST. Refreshments will be served at 5 p.m.

Berg, the Robert W. and Vivian K. Cahill Professor of Cancer Research, Emeritus, at Stanford, is a pioneer in the field of genetic engineering. He will be introduced by former U.S. Secretary of State George Shultz, the Thomas W. and Susan B. Ford Distinguished Fellow at the Hoover Institution. A 10-minute question-and-answer period will follow Berg's lecture.

The second lecture, focusing on stem cell research, will take place on Friday, Feb. 20, at 4 p.m., following a 3 p.m. reception. The lecture will be presented by stem cell researcher Dr. Irving Weissman, the Karel and Avice Beekhuis Professor of Cancer Biology at Stanford. He will be introduced by Dr. Philip Pizzo, dean of the Stanford School of Medicine.

The third lecture, on genomics and race, will be held on Wednesday, March 17, at 6 p.m., following a reception at 5 p.m. The lecture will be delivered by Stanford geneticist Marcus Feldman, the Burnet C. and Mildred Finley Wohlford Professor in the School of Humanities and Sciences. Feldman will be introduced by Paul Ehrlich, the Bing Professor of Population Studies in the Stanford Department of Biological Sciences and author of Human Natures: Genes, Culture and the Human Prospect. Lectures on other topics also are planned for April and May.

Communicating science

The Genomic Medicine Public Lecture Series was the brainchild of Renu Heller, a former scientist at Stanford and senior scientist wit
'"/>

Contact: Renu Heller
rheller@stanford.edu
650-327-4528
Stanford University
20-Jan-2004


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... CellMax ... cancer cells in blood, will present new findings at the ASCO Gastrointestinal Cancer ... colorectal cancer. The results from this study show CellMax Life’s blood test, based ...
(Date:1/10/2019)... (PRWEB) , ... January 09, 2019 , ... Dr. Beanlands ... Heart Institute in Ottawa, Ontario, Canada. He is also Director of its National ... of Medicine, in the Department of Radiology, and in the Department of Cellular and ...
(Date:1/10/2019)... ... 2019 , ... A major goal for pharmaceutical companies has ... significantly more expensive in vivo studies in order to reduce costs and improve ... researchers have begun to adopt 3D cell culture models which have been shown ...
Breaking Biology News(10 mins):
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
(Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
(Date:12/5/2018)... (PRWEB) , ... December 04, ... ... an established North American full-service contract research organization (CRO), announced the acquisition ... transaction significantly strengthens ARG’s reach and experience in the management of clinical ...
Breaking Biology Technology:
Cached News: